The long-lasting persistence of PB CD26+LSCs and the fluctuation of their values was also confirmed in 32 CML patients with stable TFR, in which flow cytometry evaluation of residual LSCs was monitored for up to 24 months (Figure 4). Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.